These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 10771022)

  • 1. Modulation of beta-amyloid precursor protein processing and tau phosphorylation by acetylcholine receptors.
    Hellström-Lindahl E
    Eur J Pharmacol; 2000 Mar; 393(1-3):255-63. PubMed ID: 10771022
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alzheimer's disease: relationship between muscarinic cholinergic receptors, beta-amyloid and tau proteins.
    Pavía J; de Ceballos ML; Sanchez de la Cuesta F
    Fundam Clin Pharmacol; 1998; 12(5):473-81. PubMed ID: 9794144
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The regulation of amyloid precursor protein metabolism by cholinergic mechanisms and neurotrophin receptor signaling.
    Rossner S; Ueberham U; Schliebs R; Perez-Polo JR; Bigl V
    Prog Neurobiol; 1998 Dec; 56(5):541-69. PubMed ID: 9775403
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acetylcholine receptors and tau phosphorylation.
    Rubio A; Pérez M; Avila J
    Curr Mol Med; 2006 Jun; 6(4):423-8. PubMed ID: 16900665
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic strategies in Alzheimer's disease: M1 muscarinic agonists.
    Fisher A
    Jpn J Pharmacol; 2000 Oct; 84(2):101-12. PubMed ID: 11128032
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Alzheimer disease: cellular and molecular aspects].
    Octave JN
    Bull Mem Acad R Med Belg; 2005; 160(10-12):445-9; discussion 450-1. PubMed ID: 16768248
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Muscarinic agonists reduce tau phosphorylation in non-neuronal cells via GSK-3beta inhibition and in neurons.
    Forlenza OV; Spink JM; Dayanandan R; Anderton BH; Olesen OF; Lovestone S
    J Neural Transm (Vienna); 2000; 107(10):1201-12. PubMed ID: 11129110
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nicotine lowers the secretion of the Alzheimer's amyloid beta-protein precursor that contains amyloid beta-peptide in rat.
    Utsuki T; Shoaib M; Holloway HW; Ingram DK; Wallace WC; Haroutunian V; Sambamurti K; Lahiri DK; Greig NH
    J Alzheimers Dis; 2002 Oct; 4(5):405-15. PubMed ID: 12446972
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tau protein directly interacts with the amyloid beta-protein precursor: implications for Alzheimer's disease.
    Smith MA; Siedlak SL; Richey PL; Mulvihill P; Ghiso J; Frangione B; Tagliavini F; Giaccone G; Bugiani O; Praprotnik D
    Nat Med; 1995 Apr; 1(4):365-9. PubMed ID: 7585068
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Alzheimer's disease: cellular and molecular aspects].
    Octave JN; Pierrot N
    Bull Acad Natl Med; 2008 Feb; 192(2):323-31; discussion 331-2. PubMed ID: 18819686
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A1 adenosine receptors accumulate in neurodegenerative structures in Alzheimer disease and mediate both amyloid precursor protein processing and tau phosphorylation and translocation.
    Angulo E; Casadó V; Mallol J; Canela EI; Viñals F; Ferrer I; Lluis C; Franco R
    Brain Pathol; 2003 Oct; 13(4):440-51. PubMed ID: 14655750
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amyloid precursor protein reduction enhances the formation of neurofibrillary tangles in a mutant tau transgenic mouse model.
    Vanden Dries V; Stygelbout V; Pierrot N; Yilmaz Z; Suain V; De Decker R; Buée L; Octave JN; Brion JP; Leroy K
    Neurobiol Aging; 2017 Jul; 55():202-212. PubMed ID: 28464981
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cholinergic System and Post-translational Modifications: An Insight on the Role in Alzheimer's Disease.
    Ahmed T; Zahid S; Mahboob A; Farhat SM
    Curr Neuropharmacol; 2017; 15(4):480-494. PubMed ID: 27012953
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Roles of O-GlcNAcylation on amyloid-β precursor protein processing, tau phosphorylation, and hippocampal synapses dysfunction in Alzheimer's disease.
    Zheng BW; Yang L; Dai XL; Jiang ZF; Huang HC
    Neurol Res; 2016 Feb; 38(2):177-86. PubMed ID: 27078700
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interactions between the amyloid and cholinergic mechanisms in Alzheimer's disease.
    Pákáski M; Kálmán J
    Neurochem Int; 2008 Nov; 53(5):103-11. PubMed ID: 18602955
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The pharmacology of amyloid precursor protein processing.
    Racchi M; Govoni S
    Exp Gerontol; 2003; 38(1-2):145-57. PubMed ID: 12543272
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cholinergic Mechanisms in the Cerebral Cortex: Beyond Synaptic Transmission.
    Ovsepian SV; O'Leary VB; Zaborszky L
    Neuroscientist; 2016 Jun; 22(3):238-51. PubMed ID: 26002948
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Tau, amyloid and Alzheimer's disease].
    Olesen OF
    Ugeskr Laeger; 1994 Feb; 156(8):1116-7, 1121-4. PubMed ID: 8116089
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Brain ischemia with Alzheimer phenotype dysregulates Alzheimer's disease-related proteins.
    Ułamek-Kozioł M; Pluta R; Bogucka-Kocka A; Januszewski S; Kocki J; Czuczwar SJ
    Pharmacol Rep; 2016 Jun; 68(3):582-91. PubMed ID: 26940197
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cholinergic activity and amyloid precursor protein processing in aging and Alzheimer's disease.
    Zhang X
    Curr Drug Targets CNS Neurol Disord; 2004 Apr; 3(2):137-52. PubMed ID: 15078189
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.